Delivery Order 36E79726D0010-15B10126F00000062
- Not listed
- Seqirus USA Inc. has been awarded a delivery order by the Federal Correctional Institution Big Spring, a civilian facility under the Department of Justice, to supply influenza vaccines for the 2026-2027 season. The contract is a firm fixed-price delivery order with a ceiling value of $6,999.60 and an ultimate completion date of April 30, 2026. The vaccine will be delivered to the contractor's headquarters location in Summit, New Jersey. This award carries no set-aside designation, reflecting the...
- Seqirus USA Inc. was awarded a $3,102 firm-fixed-price delivery order by the Federal Correctional Institution Williamsburg for influenza virus vaccine for the 2025-2026 season. The award was made on September 18, 2025, with an ultimate completion date of September 30, 2025, and does not utilize a set-aside designation. The place of performance is Summit, New Jersey, where Seqirus maintains its primary operations as a leading supplier of seasonal flu vaccines to federal agencies. This delivery...
- The Federal Correctional Complex Beaumont awarded a $17,836.50 firm-fixed-price delivery order to Seqirus USA Inc. for 2025 flu vaccines targeting the inmate population at the facility in Summit, New Jersey. The contract, which was awarded and completed on September 30, 2025, did not utilize a set-aside designation, reflecting Seqirus's competitive standing in federal vaccine procurement. This delivery order falls under the Department of Justice Bureau of Prisons' broader vaccine supply strategy...
- The Federal Correctional Institution Big Spring awarded a delivery order to Seqirus USA Inc. for staff influenza vaccine supplies for the 2026-2027 season. This firm fixed-price delivery order, valued at $2,333.20, was issued on March 13, 2026, with a completion date of April 30, 2026. The order is being fulfilled from Seqirus's facility in Summit, New Jersey, with no set-aside designation applied. This delivery order represents a routine procurement to support annual flu vaccination...
- The Federal Correctional Institution Aliceville, a civilian agency within the Department of Justice Bureau of Prisons, awarded a delivery order to Seqirus USA Inc. for influenza vaccines in FY 2025. This firm-fixed-price contract, valued at $8,930.28, was awarded on April 15, 2025, with an ultimate completion date of May 30, 2025. The contract contains no set-aside designation, reflecting Seqirus's competitive standing in the federal marketplace. Performance will take place at the contractor's...
- Seqirus USA Inc. was awarded a firm fixed price delivery order by the Department of Justice Bureau of Prisons Federal Correctional Institution Greenville to supply inmate influenza vaccines. The $7,610.06 contract has a completion date of February 20, 2024 and was awarded on March 30, 2021 without a set-aside designation. As the prime contractor, Seqirus USA Inc. will deliver influenza virus vaccines to support immunization programs for federal inmates and correctional facility staff at the...
- Seqirus USA Inc. was awarded a firm fixed-price delivery order valued at $1,762.92 to supply influenza virus vaccine for the 2025-2026 season to the inmate population at Federal Correctional Institution Jesup, Georgia. The contract, issued on April 1, 2025, with an ultimate completion date of October 31, 2025, is being funded by the Bureau of Prisons under the Department of Justice. This delivery order is issued under Contract No. 36E79725D0006 and does not utilize a set-aside designation,...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Aliceville awarded a $3,978.60 delivery order contract to Seqirus USA Inc. for influenza vaccinations for staff. Under this firm fixed price contract, Seqirus USA Inc. Division will provide Seqirus flu vaccine to the Bureau of Prisons facility in Summit, New Jersey through December 31, 2022. No additional details were provided on subcontractors or the scope of the original solicitation. The contract utilizes an existing...
- Seqirus USA Inc. has been awarded a delivery order valued at $2,914.14 by the Federal Medical Center Carswell for inmate flu vaccine supply at FCI Bastrop under a firm fixed-price arrangement with no set-aside designation. The contract, issued on March 20, 2025, is scheduled for completion by October 31, 2025, and represents a continuation of Seqirus's established role as a critical supplier of influenza vaccines to the Bureau of Prisons and other federal healthcare systems. The work will be...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Terre Haute awarded a $3,728.70 firm fixed price delivery order contract to Seqirus USA Inc. for FY 2022 influenza vaccinations for inmates over 65 years of age. Seqirus USA Inc. will provide the vaccines with performance taking place in Summit, New Jersey under the one year contract running from July 18, 2022 through September 30, 2022. No set aside designation or subcontractors were indicated. The delivery order was...
- 36E79726D0010Indefinite Delivery Contract
- 36E79726D0010-15B10126F00000062Delivery Order
Seqirus USA Inc., a biotechnology company headquartered in Summit, New Jersey, was awarded a delivery order by the Federal Prison Camp Alderson (a civilian facility under the Bureau of Prisons) for inmate flu vaccine services in the second quarter of fiscal year 2026. The contract, valued at $2,541.60, is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of September 30, 2026. Performance will take place in Alderson, West Virginia. This delivery order falls under Seqirus's established relationship with the Bureau of Prisons, which has issued the company numerous orders across correctional institutions nationwide for comprehensive influenza vaccination programs serving both inmate and staff populations. Seqirus maintains a substantial federal contracting presence across multiple agencies, including indefinite delivery contracts with the Veterans Affairs National Acquisition Center, the Centers for Disease Control and Prevention (valued at up to $410.6 million for pediatric vaccines and $245.6 million for adult vaccines), and the Defense Logistics Agency's Medical Supply Chain, positioning the company as a critical supplier of seasonal influenza vaccines throughout the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/15/26 |